References
- Lebedevs T, Kendrick C. Pharmacological management of common lactation problems. J Res Pharm Pract. 2019;49(2):192–198. doi: 10.1002/jppr.1561
- Wada Y, Suyama F, Amari S, et al. Effects of Domperidone in Increasing Milk Production in Mothers with Insufficient Lactation for Infants in the Neonatal Intensive Care Unit. Breastfeed Med. 2019;14(10):744–747. doi: 10.1089/bfm.2019.0111
- Obstetrics and Gynaecology Directorate Women and Newborn Health Services. Newborn Feeding and Maternal Lactation. 2023; Version 2: February 2023. Available from:
https://healthpoint.hdwa.health.wa.gov.au/policies/Policies/NMAHS/WNHS/WNHS.OG.NewbornFeedingAndMaternalLactation.pdf - Department of Health and Aged Care. Domperidone (Motilium) and effects on the heart. Therapeutics Goods Administration. April 2, 2014. Available from:
https://www.tga.gov.au/news/safety-alerts/domperidone-motilium-and-effects-heart#:~:text=The%20TGA%20is%20reviewing%20new%20information%20regarding%20domperidone,of%20nausea%20and%20vomiting%2C%20and%20delayed%20stomach%20emptying - Knoppert DC, Page A, Warren J, et al. The effect of two different domperidone doses on maternal milk production. J Hum Lact. 2013;29(1):38–44. doi: 10.1177/0890334412438961
- Brodribb W. ABM Clinical Protocol #9: Use of galactogogues in initiating or augmenting maternal milk production, Second Revision 2018. Breastfeed Med. 2018; 13(5):307–314. doi: 10.1089/bfm.2018.29092.wjb
- Sadovnikova A, Sommers J, Oberhelman S. Preliminary results from a survey of the pharmacologic, herbal, and nutritional galactagogue prescribing practices of physicians in the united states and canada. In: The Academy of Breastfeeding Medicine. Abstracts. 25th Annual International Meeting; 2020 Nov 5–7; Online.
- Hondeghem LM, Logghe NH. should domperidone be used as a galactagogue? Possible safety implications for mother and child. Drug Safety. 2017;40(2):109–113. doi; 10.1007/s40264-016-0478-x.
- How to Request Domperidone for Expanded Access Use. US Food & Drug Administration. Updated February 2, 2021. Available from:
https://www.fda.gov/drugs/investigational-new-drug-ind-application/how-request-domperidone-expanded-access-use - McBride GM, Stevenson R, Zizzo G, et al. Use and experiences of galactagogues while breastfeeding among Australian women. PLoS ONE. 2021;1(16):7. doi: 10.1371/journal.pone.025049
- Tauritz Bakker LA, van Dijk L, van den Bemt PMLA. Exploring the prescribing process of domperidone for low milk supply: A qualitative study among mothers, IBCLCs, and family doctors. J Hum Lact. 2021;37(4):748–760. doi:10.1177/0890334420964070
- Grzeskowiak LE. Audit of domperidone use as a galactogogue at a major tertiary teaching hospital. J Paediatr Child Health. 2012;48(1):8–81.
- Mehrabadi A, Reynier P, Root A, Platt RW, Filion KB. The use of domperidone for insufficient lactation in England between 2002 and 2015: A drug utilization study with interrupted time-series analysis. Pharmacoepidemiol Drug Saf. 2017;26(suppl 2):579. doi: 10.1002/pds
- Khorana M, Wongsin P, Torbunsupachai R, Kanjanapattanakul W. effect of domperidone on breast milk production in mothers of sick neonates: A randomized, double-blinded, placebo-controlled trial. Breastfeed Med. 2021;16(3):245–250. doi:10.1089/bfm.2020.0234
- Grzeskowiak LE, Amir LH. Pharmacological management of low milk supply with domperidone: separating fact from fiction. Med J Aust. 2014;201(5):257–258. doi: 10.5694/mja14.00626
- Asztalos EV, Kiss A, da Silva OP, Campbell-Yeo M, Ito S, Knoppert D. Evaluating the effect of a 14-day course of domperidone on breast milk production: A per-protocol analysis from the EMPOWER trial. Breastfeed Med. 2019;14(2):102–107. doi: 10.1089/bfm.2018.0175
- Taylor A, Logan G, Twells L, Newhook LA. Human milk expression after domperidone treatment in postpartum women: A systematic review and meta-analysis of randomized controlled trials. J Hum Lact. 2019;35(3):501–509. doi: 10.1177/0890334418812069
- Foong SC, Tan ML, Foong WC, Marasco LA, Ho JJ, Ong JH. Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non-hospitalised term infants. Cochrane Database Syst Rev. 2020;(5):CD011505. doi: 10.1002/14651858.CD011505.pub2
- Asztalos EV, Campbell-Yeo M, da Silva OP, et al. Enhancing human milk production with domperidone in mothers of preterm infants: Results from the EMPOWER trial. J Hum Lact. 2017;33(1):181–187. doi:10.1177/0890334416680176
- Doyle M, Grossman M. Case report: domperidone use as a galactagogue resulting in withdrawal symptoms upon discontinuation. Arch Women’s Men Health. 2018;21(4):461–463. doi: 10.1007/s00737-017-0796-8
- Smolina K, Mintzes B, Hanley GE, Oberlander TF, Morgan SG. The association between domperidone and ventricular arrhythmia in the postpartum period. Pharmacoepidemiol Drug Saf. 2016;25(10):1210–1214. doi:10.1002/pds.4035
- Hasse B, Taylor SN, Mauldin J, Johnson TS, Wagner CL. Domperidone for treatment of low milk supply in breast pump–dependent mothers of hospitalized premature infants: A clinical protocol. J Hum Lact. 2016;32(2):373–381. doi: 10.1177/0890334416630539
- Andrew B, Smith R. Domperidone safety checklist [leaflet]. Adelaide Mums and Babies Clinic; 2019.
- Gilmartin CE, Amir LH, Ter M, Grzeskowiak LE. Using domperidone to increase breast milk supply: A clinical practice survey of Australian neonatal units. J Res Pharm Pract. 2017;47(6):426–430.
- Government of Western Australia. Structured administration and supply arrangements. Department of Health. 2023. Available from:
https://www.health.wa.gov.au/Articles/S_T/Structured-Administration-and-Supply-Arrangements